FdaApplication
NDA 200063
Identifiers
- fda_app_no: NDA200063
Properties
| Property | Value |
|---|---|
| applicant_name | AZURITY PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2014-09-10 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CONTRAVE | BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE | 90MG;8MG | TABLET, EXTENDED RELEASE;ORAL |
1 product